Karrin Weisenthal, MD, MHS

Assistant Professor, Boston University Chobanian & Avedisian School of Medicine

Biography

Karri Weisenthal, M.D./M.H.S. is an Assistant Professor of Emergency Medicine at the Boston University Chobanian and Avedisian School of Medicine, the Associate Medical Director of Faster Paths to Treatment, Boston Medical Center’s low-barrier addiction bridge clinic, and the Medical Director for the integrated ED Addiction Consult Team. She graduated cum laude from the Yale School of Medicine and completed her residency training in Emergency Medicine and Addiction Medicine fellowship at Boston Medical Center.

Dr. Weisenthal is an active researcher in the fields of Emergency and Addiction Medicine, and she was awarded the SAEM Foundation/NIDA Mentor Facilitated Training Award to develop a curriculum on the incorporation of harm reduction into the care of patients who access emergency services. Her current research interests include improving initiation and access to medications for opioid use disorder in the emergency department (ED) with an equity lens, ensuring smooth transitions of care from the ED to outpatient settings, and integrating a harm reduction approach into the care of patients in the ED.

Publications

  • Published 2/17/2025

    Peterkin AF, Laks J, Farrell N, Weisenthal K, Taylor JL. Outpatient Alcohol Withdrawal Management in a Substance Use Disorder Bridge Clinic: An Opportunity for Low-barrier Engagement and Shared Decision-making. J Addict Med. 2025 Feb 17. PMID: 39961087.

    Read at: PubMed

  • Published 5/12/2024

    Taylor JL, Gott J, Weisenthal K, Colicchio P, Dyer S, Komaromy MS. Post-Overdose Extended-Release Buprenorphine Initiation Facilitated by a Partnership Between Emergency Medical Services and an Outpatient Substance Use Disorder Observation Unit. Subst Use Addctn J. 2024 Oct; 45(4):771-776. PMID: 38736211.

    Read at: PubMed

  • Published 7/29/2022

    Weisenthal K, Kimmel SD, Kehoe J, Larochelle MR, Walley AY, Taylor JL. Effect of police action on low-barrier substance use disorder service utilization. Harm Reduct J. 2022 Jul 29; 19(1):86. PMID: 35906660.

    Read at: PubMed

  • Published 5/13/2022

    Zhao W, Jiang X, Weisenthal K, Ma J, Botticelli EM, Zhou Y, Hedley-Whyte ET, Wang B, Swearingen B, Soberman RJ, Klibanski A, Zhang X. High Histone Deacetylase 2/3 Expression in Non-Functioning Pituitary Tumors. Front Oncol. 2022; 12:875122. PMID: 35646715.

    Read at: PubMed

  • Published 6/9/2021

    Moore CL, Bhargavan-Chatfield M, Shaw MM, Weisenthal K, Kalra MK. Radiation Dose Reduction in Kidney Stone CT: A Randomized, Facility-Based Intervention. J Am Coll Radiol. 2021 10; 18(10):1394-1404. PMID: 34115990.

    Read at: PubMed

View All 9 Publications:   View Full Profile in BUMC

Websites

Education

  • Yale University School of Medicine, MD
  • Yale University School of Medicine, MHS
  • Yale University, BA

View all profiles